EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C4H6N2 |
| Net Charge | 0 |
| Average Mass | 82.106 |
| Monoisotopic Mass | 82.05310 |
| SMILES | Cc1cnnc1 |
| InChI | InChI=1S/C4H6N2/c1-4-2-5-6-3-4/h2-3H,1H3,(H,5,6) |
| InChIKey | RIKMMFOAQPJVMX-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | EC 1.1.1.1 (alcohol dehydrogenase) inhibitor An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that interferes with the action of alcohol dehydrogenase (EC 1.1.1.1). |
| Applications: | antidote Any protective agent counteracting or neutralizing the action of poisons. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. protective agent Synthetic or natural substance which is given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| fomepizole (CHEBI:5141) has parent hydride 1H-pyrazole (CHEBI:17241) |
| fomepizole (CHEBI:5141) has role antidote (CHEBI:50247) |
| fomepizole (CHEBI:5141) has role EC 1.1.1.1 (alcohol dehydrogenase) inhibitor (CHEBI:50269) |
| fomepizole (CHEBI:5141) has role ophthalmology drug (CHEBI:66981) |
| fomepizole (CHEBI:5141) has role protective agent (CHEBI:50267) |
| fomepizole (CHEBI:5141) is a pyrazoles (CHEBI:26410) |
| IUPAC Name |
|---|
| 4-methyl-1H-pyrazole |
| INNs | Source |
|---|---|
| fomepizol | DrugBank |
| fomepizole | DrugBank |
| fomepizolum | DrugBank |
| Synonyms | Source |
|---|---|
| 4-Methylpyrazol | ChemIDplus |
| 4-Methylpyrazole | KEGG COMPOUND |
| 4-MP | ChEMBL |
| NSC-760365 | ChEMBL |
| Brand Name | Source |
|---|---|
| Antizol | DrugBank |
| Manual Xrefs | Databases |
|---|---|
| 1233 | DrugCentral |
| 4PZ | PDBeChem |
| C07837 | KEGG COMPOUND |
| D00707 | KEGG DRUG |
| DB01213 | DrugBank |
| Fomepizole | Wikipedia |
| HMDB0015344 | HMDB |
| LSM-5671 | LINCS |
| Citations |
|---|